Microvascular disease confers additional risk to COVID-19 infection.

Bale BF, Doneen AL, Vigerust DJ
Med Hypotheses. 2020 144: 109999

PMID: 32570168 · PMCID: PMC7294251 · DOI:10.1016/j.mehy.2020.109999

The majority of fatalities thus far in the COVID-19 pandemic have been attributed to pneumonia. As expected, the fatality rate reported in China is higher in people with chronic pulmonary disease (6.3%) and those who have cancer (5.6%). According to the American College of Cardiology Clinical Bulletin "COVID-19 Clinical Guidance for the CV Care Team", there is a significantly higher fatality rate in people who are elderly (8.0% 70-79 years; 14.8% ≥80 years), diabetic (7.3%), hypertensive (6.0%), or have known cardiovascular disease (CVD) (10.5%). We propose a biological reason for the higher mortality risk in these populations that is apparent. We further present a set of pathophysiological reasons for the heightened danger that could lead to therapies for enhanced management and prevention.

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

MeSH Terms (20)

Adult Aging Cardiovascular Diseases Child COVID-19 Diabetes Mellitus Disease Susceptibility Humans Hydrogen Peroxide Hypertension Hypochlorous Acid Immunity, Innate Lung Microcirculation Microvessels Neutrophils Pandemics Peroxidase Risk Factors United States

Connections (1)

This publication is referenced by other Labnodes entities: